SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 2c
Get Alerts SLS Hot Sheet
Join SI Premium – FREE
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- Boeing lands two U.S. defense contracts worth over $711M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share